Hosted by Bristol Vision Institute (BVI)
Cuttlefish, octopus and squid don’t see colour and instead they see the polarization of light. Dr Temple developed new ways of testing polarization sensitivity in cephalopods and in the process discovered that he had inadvertently developed a new way for measuring a key risk factor for the leading cause of incurable blindness in humans (age-related macular degeneration). Dr Temple patented the technique and spun out a company (azulOptics Ltd) to translate the idea into an ophthalmic device that is now used by optometrists and ophthalmologists in over a dozen countries. Come and learn about the voyage of discovery, translation, clinical trials, product development, marketing, business and how this new tool is helping people protect their eyes.
The talk be followed by drinks, Christmasy nibbles and an opportunity for networking and conversation.
Further details are available on our seminar webpage, including how to join us online if you are unable to attend in-person.